Postoperative time (h) | Group P (n = 47) | Group A (n = 46) |
---|
0−2 | 15 | 13 |
2−6 | 7 | 9 |
6−24 | 4 | 4 |
24−48 | 0 | 1 |
Total incidence | 26 | 27 |
Total patients | 17 | 20 |
- The data represent the number of patients. Group P was given 0.075 mg of palonosetron intravenously, whereas group A was given 40 mg of oral aprepitant. The total number of patients excludes the number of patients with repeated administration (5 patients in the palonosetron group and 4 patients in the aprepitant group). No significant differences were observed between groups P and A.